News Archive - COVID-19

UC San Diego Joins Second Major National Clinical Trial for Novel Coronavirus

UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.

Researchers See an Increase in Fraudulent COVID-19 Posts on Social Media

In a new study from UC San Diego School of Medicine, thousands of fake social media posts tied to COVID-19 and financial scams are found on two popular platforms.

Is COVID-19 Transmitted Through Breast Milk? Study Suggests Not Likely

A recent study by researchers at University of California San Diego School of Medicine suggests transmission of COVID-19 through breast milk is not likely. The infectious virus was not detected in 64 samples of breast milk tested.

UC San Diego Named 4th Best Public Research University in Prestigious Global Rankings

The University of California San Diego has been named the fourth best public university in the United States for the second consecutive year by the 2020 Academic Ranking of World Universities (ARWU).

Imitation May Be a Sincere Form of Treatment

The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.

National Clinical Trial Launches, Will Test Promising Vaccine Against Novel Coronavirus

UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.

New Model Connects Respiratory Droplet Physics with Spread of Covid-19

Engineers have incorporated a new understanding of the impact of environmental factors on droplet spread into a mathematical model that can be used to predict the early spread of respiratory viruses including COVID-19, and the role of respiratory droplets in that spread.

A Nanomaterial Path Forward for COVID-19 Vaccine Development

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.

Trade Wars with China Could Cost U.S. Universities $1.15 Billion

Uncertainties around the trade war between the U.S. and China have hurt businesses and weighed on the global economy. However, new research from the University of California San Diego also shows lesser known consequence: up to $1.15 billion in reduced tuition to U.S. universities.

Does Blood Plasma from COVID-19 Survivors Help Patients Infected with Novel Coronavirus?

Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.